Answers are grounded in this paper and cite their sources.
Review summarizes persistent B cell aplasia outcomes, therapies, and in vitro modeling strategies in human B cell development.
• We revise the clinical occurrence of persistent B cell aplasia and hypogammaglobulinemia upon B cell deple on. • We summarize the impact of the bone marrow niche on B lymphopoiesis. • We describe the state of the art in in vitro modeling of human B cell development from feeder-based, feeder-free and iPSC cultures to bone marrow organoid models. The B cell compartment is maintained by continuous replenishment from hematopoietic stem cells (HSCs) and multipotent progenitors, as well as from B cell precursors. B cell depletion is a common therapeutic approach, not only in the context of B cell malignancies, but also in autoimmunity. The targeted elimination of B cells can be achieved through the use of chimeric antigen receptor (CAR)-T cells or monoclonal antibodies or bispecific antibodies that target both B and NK cells or B and T cells. When B cells are depleted, repopulation from bone marrow precursors occurs within three months to one year, following ontogeny. Nevertheless, prolonged B cell aplasia is observed in some patients and is associated with a progressive reduction of serum immunoglobulins and an increased susceptibility to infections. The mechanisms underlying such defects in B cell replenishment remain to be fully elucidated and studies on human B lymphopoiesis are needed in this context. Mouse models can be helpful in studying mechanisms of B cell development and the role of multiple (B cell-specific) genes in this process; however, they do not always mirror the human developmental dynamics and signals. Hence further tools are needed to study human B lymphopoiesis defects. In this review, we summarize the reported studies and cases of prolonged B cell aplasia following B cell depletion and discuss potential underlying causes. We then provide a comprehensive overview of the various in vitro models that can be used to study the dynamic of B lymphopoiesis to dissect B cell developmental defects in humans.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: